Checking childhood cancer survivors at risk for sensory problems
Tests a record-based alert to prompt sensory screening in childhood cancer survivors.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Registry title
- Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
- Status
- Recruiting
- People taking part
- 146 people, planned
- Started
- 2 Aug 2023
- Expected to end
- 31 May 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Highlighting Patients at Risk for Sensory Screening (HPARSS)
- Record updated
- 15 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teens who had cancer and finished treatment 6 months to 2 years ago. It tests a tool that flags who needs hearing and vision screening.
- Age
- 7 to 17 years old
- Sex
- All sexes can join.
- Disease stage
- Cancer diagnosed before age 18, with all cancer treatment finished.
- Earlier treatment
- Must have had chemotherapy and/or radiation therapy. All cancer therapy must have ended at least 6 months and less than 2 years ago.
Main reasons for not taking part
- Currently in active cancer treatment
- In the care of the Late Effects Program at St. Louis Children's Hospital
- Already had diagnostic testing or rehabilitative therapy for a deficit that screening covers
- No contact with the treatment team in the past two years
- In foster care or without a legal guardian
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patients with a diagnosis of pediatric cancer (diagnosis at <18 years of age)
- Treatment including chemotherapy and/or radiation therapy
- Completion of all cancer therapy for at least 6 months and less than 2 years
- Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
- Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
- English speaking
Who cannot take part
- Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening
- Undergoing active cancer treatment
- Patient under the care of the Late Effects Program at St. Louis Children's Hospital
- Parents and/or patient illiteracy
- No contact with treatment team in the past two years
- In foster care or without a legal guardian
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 17 years old?
Where in United States
- St. Louis Children's Hospital - Washington University School of MedicineSt Louis, United StatesContact: Robert J Hayashi, M.D.Taking people
About the trial
What the trial wants to find out
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.
The 2 groups in the trial
- Patients: Highlighting Patients at Risk for Sensory Screening (HPARSS)Treatment being tested
* The primary oncology team will utilize the HPARSS to identify patients who are at risk for sensory deficits based on prior treatment. The HPARSS will constitute a file of that will contain eligible patients based upon their past treatment and their corresponding risk for a particular sensory deficit based upon that treatment. The patient and parent/guardian will be approached to participate in the study. * Sensory deficit screening will be completed in the clinic and any screening results that indicate the need for referral for diagnostic testing or therapy will be scheduled by the primary treatment team staff.
Treatment: Highlighting Patients at Risk for Sensory Screening (HPARSS)
- Providers: Highlighting Patients at Risk for Sensory Screening (HPARSS)No study treatment, for comparison
-Providers will complete a survey regarding their views of the HPARSS. The Acceptability of Intervention Measure has 4 questions and the Feasibility of Intervention Measure has 4 questions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
- Plain-language title
- Checking childhood cancer survivors at risk for sensory problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05582551, who can take part
- Record updated
- 15 June 2026